News tagged with cell lymphoma
Microbiologists identify two molecules that kill lymphoma cells in mice
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Nov 06, 2011 |
5 / 5 (5) |
2
|
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
Humble protein, nanoparticles tag-team to kill cancer cells
(PhysOrg.com) -- A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles ...
Nanotechnology / Bio & Medicine
Jul 30, 2010 |
5 / 5 (5) |
0
|
Scientists find new way to attack cancerous cells
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Jun 07, 2010 |
5 / 5 (11) |
0
|
'Junk DNA' drives cancer growth
Researchers from the University of Leeds, UK, the Charite University Medical School and the Max Delbruck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force behind cancer growth.
May 02, 2010 |
4.9 / 5 (12) |
4
|
New way to kill cancer found using body's immune system
(PhysOrg.com) -- Scientists have discovered a new way of killing cancer cells in a breakthrough that could eventually lead to new treatments for a range of different cancers.
Jul 21, 2009 |
5 / 5 (9) |
6
Jarid2 may break the Polycomb silence
Historically, fly and human Polycomb proteins were considered textbook exemplars of transcriptional repressors, or proteins that silence the process by which DNA gives rise to new proteins. Now, work by a ...
Apr 30, 2012 |
5 / 5 (1) |
0
|
Worm studies shed light on human cancers
(PhysOrg.com) -- Research in the worm is shedding light on a protein associated with a number of different human cancers, and may point to a highly targeted way to treat them.
Apr 21, 2011 |
not rated yet |
0
|
Researchers predict age of T cells to improve cancer treatment
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's ...
Mar 02, 2011 |
not rated yet |
0
|
Study shows how dietary supplement may block cancer cells
Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have discovered how a substance that is produced when eating broccoli ...
Jun 29, 2010 |
4 / 5 (17) |
0
|
Control of cancer cell pathways key to halting disease spread, study shows
Oncogenes are like friends who've gone off the deep end. Normally steady, reliable members of the cellular workforce, these genes become very bad influences when mutated or expressed at high levels -- urging a cell to divide ...
Jun 14, 2010 |
5 / 5 (1) |
0
|
A new target for lymphoma therapy
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to cancer and ...
Dec 09, 2009 |
not rated yet |
0
Researchers restore some function to cells from cystic fibrosis patients
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before ...
Dec 06, 2009 |
5 / 5 (1) |
0
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Nov 22, 2009 |
5 / 5 (1) |
0
Research puts a 'Fas' to the cause of programmed cell death
Walter and Eliza Hall Institute researchers have put an end to a 10-year debate over which form of a molecular messenger called Fas ligand is responsible for killing cells during programmed cell death (also ...
Medicine & Health / Medical research
Sep 30, 2009 |
4.7 / 5 (3) |
0
